229 related articles for article (PubMed ID: 14671485)
1. The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production.
Gálvez J; Garrido M; Rodríguez-Cabezas ME; Ramis I; de Medina FS; Merlos M; Zarzuelo A
Inflamm Bowel Dis; 2003 Nov; 9(6):363-71. PubMed ID: 14671485
[TBL] [Abstract][Full Text] [Related]
2. The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis.
Camuesco D; Rodríguez-Cabezas ME; Garrido-Mesa N; Cueto-Sola M; Bailón E; Comalada M; Arribas B; Merlos M; Balsa D; Zarzuelo A; Janer G; Xaus J; Román J; Gálvez J
Br J Pharmacol; 2012 Feb; 165(3):729-40. PubMed ID: 21790535
[TBL] [Abstract][Full Text] [Related]
3. Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat.
Gálvez J; Garrido M; Merlos M; Torres MI; Zarzuelo A
Br J Pharmacol; 2000 Aug; 130(8):1949-59. PubMed ID: 10952687
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
5. Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
Choi KC; Cho SW; Kook SH; Chun SR; Bhattarai G; Poudel SB; Kim MK; Lee KY; Lee JC
J Ethnopharmacol; 2016 Feb; 179():55-65. PubMed ID: 26721217
[TBL] [Abstract][Full Text] [Related]
6. Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat.
Gálvez J; Coelho G; Crespo ME; Cruz T; Rodríguez-Cabezas ME; Concha A; Gonzalez M; Zarzuelo A
Aliment Pharmacol Ther; 2001 Dec; 15(12):2027-39. PubMed ID: 11736735
[TBL] [Abstract][Full Text] [Related]
7. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
[TBL] [Abstract][Full Text] [Related]
8. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
[TBL] [Abstract][Full Text] [Related]
9. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of rectal administration of muscovite on experimental colitis in rats.
Chen Y; Chen Y; Liu WL; Zhou TH; Cai JT; Du Q; Wang LJ; Wu JG; Si JM
J Gastroenterol Hepatol; 2009 May; 24(5):912-9. PubMed ID: 19220658
[TBL] [Abstract][Full Text] [Related]
11. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J
J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209
[TBL] [Abstract][Full Text] [Related]
12. The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition.
Bailón E; Camuesco D; Nieto A; Concha A; Fernández de Arriba A; Román J; Ramis I; Merlos M; Zarzuelo A; Gálvez J; Comalada M
Biochem Pharmacol; 2007 Nov; 74(10):1496-506. PubMed ID: 17720145
[TBL] [Abstract][Full Text] [Related]
13. Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats.
Rodríguez-Cabezas ME; Gálvez J; Lorente MD; Concha A; Camuesco D; Azzouz S; Osuna A; Redondo L; Zarzuelo A
J Nutr; 2002 Nov; 132(11):3263-71. PubMed ID: 12421838
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
Karrout Y; Dubuquoy L; Piveteau C; Siepmann F; Moussa E; Wils D; Beghyn T; Neut C; Flament MP; Guerin-Deremaux L; Dubreuil L; Deprez B; Desreumaux P; Siepmann J
J Control Release; 2015 Jan; 197():121-30. PubMed ID: 25445696
[TBL] [Abstract][Full Text] [Related]
15. Intestinal anti-inflammatory activity of calcium pyruvate in the TNBS model of rat colitis: Comparison with ethyl pyruvate.
Algieri F; Rodriguez-Nogales A; Garrido-Mesa J; Camuesco D; Vezza T; Garrido-Mesa N; Utrilla P; Rodriguez-Cabezas ME; Pischel I; Galvez J
Biochem Pharmacol; 2016 Mar; 103():53-63. PubMed ID: 26774455
[TBL] [Abstract][Full Text] [Related]
16. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis.
Camuesco D; Comalada M; Concha A; Nieto A; Sierra S; Xaus J; Zarzuelo A; Gálvez J
Clin Nutr; 2006 Jun; 25(3):466-76. PubMed ID: 16698151
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of endogenous nitric oxide activity impairs the colonic sparing effect of rofecoxib, the cyclooxygenase-2 inhibitor and resveratrol, the preferential cyclooxygenase-1 inhibitor in the course of experimental colitis. Role of oxidative stress biomarkers and proinflammatory cytokines.
Kwiecień S; Wojcik-Grzybek D; Sliwowski Z; Targosz A; Chmura A; Magierowska K; Strzalka M; Glowacka U; Ptak-Belowska A; Magierowski M; Brzozowski T
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085520
[TBL] [Abstract][Full Text] [Related]
18. Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.
Varga G; Ugocsai M; Hartmann P; Lajkó N; Molnár R; Szűcs S; Jász DK; Érces D; Ghyczy M; Tóth G; Boros M
Inflammopharmacology; 2018 Feb; 26(1):261-271. PubMed ID: 28451776
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis.
Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Adrio JL; Olivares M; Xaus J; Zarzuelo A; Galvez J
Int J Colorectal Dis; 2006 Dec; 21(8):737-46. PubMed ID: 16052308
[TBL] [Abstract][Full Text] [Related]
20. Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.
Camuesco D; Peran L; Comalada M; Nieto A; Di Stasi LC; Rodriguez-Cabezas ME; Concha A; Zarzuelo A; Galvez J
Inflamm Bowel Dis; 2005 Mar; 11(3):265-71. PubMed ID: 15735433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
